Abstract
Purpose
To evaluate EGFR and HER2 copy number changes and to assess their significance to tumor progression in a large group of patients with larynx cancer through the construction of a tissue microarray (TMA) consisting of 1,385 biopsies.
Methods
Fluorescent in situ hybridization (FISH) was applied to analyze the tumors. FISH was successful for EGFR in 1,080 (77.98%) and for HER2 in 683 (49.31%).
Results
HER2 was amplified in 1.02% of cases. Amplification did not correlate with the tumor phenotype-clinical stage, and grade. The low frequency of amplification of HER2 oncogene in larynx tumors showed that the mechanism responsible for the high level of receptor overexpression still remains unclear in the majority of cases. Amplification of EGFR was found in 10.37% of cases. The analysis revealed a lack of correlation between amplification of the oncogenes and the tumor phenotype. We observed a lack of difference between the samples of primary tumors and advanced disease carcinomas—tumors with regional/distant metastases and recurrent tumors regarding oncogene amplification.
Conclusion
These results suggest that EGFR amplification is a relatively rare event in larynx carcinogenesis that obviously does not predispose to tumor progression.
Similar content being viewed by others
References
Almadori G, Cadoni G, Galli J, Ferrandina G, Scambia G, Exarchakos G, Paludetti G, Ottaviani F (1999) Epidermal growth factor receptor expression in primary laryngeal cancer: an independent prognostic factor of neck node relapse. Int J Cancer 84:188–191
Almadori G, Cadoni G, Cattani P, Galli J, Bussu F, Ferrandina G, Scambia G, Fadda G, Maurizi M (2001) Human papillomavirus infection and epidermal growth factor receptor expression in primary laryngeal squamous cell carcinoma. Clin Cancer Res 7:3988–3993
Arteaga CL (2002) Epidermal growth factor receptor dependence in human tumors. More than just expression? Oncologist 7:31–39
Ashman JN, Patmore HS, Condon LT, Cawkwell L, Stafford ND, Greenman J (2003) Prognostic value of genomic alterations in head and neck squamous cell carcinoma detected by comparative genomic hybridisation. Br J Cancer 89:864–869
Bergamo NA, Rogatto SR, Poli-Frederico RC, Reis PP, Kowalski LP, Zielenska M, Squire JA (2000) Comparative genomic hybridization analysis detects frequent over-representation of DNA sequences at 3q, 7p, and 8q in head and neck carcinomas. Cancer Genet Cytogenet 119:48–55
Bubendorf L, Nocito A, Moch H, Sauter G (2001) Tissue microarray (TMA) technology: miniaturized pathology archives for high-throughput in situ studies. J Pathol 195:72–79
Bockmuhl U, Petersen I, Schwendel A, Dietel M (1996a) Genetic screening of head-neck carcinomas using comparative genomic hybridization (CGH). Laryngorhinootologie 75:408–414
Bockmuhl U, Schwendel A, Dietel M, Petersen I (1996b) Distinct patterns of chromosomal alterations in high- and low-grade head and neck squamous cell carcinomas. Cancer Res 56:5325–5329
Bockmuhl U, Petersen S, Schmidt S, Wolf G, Jahnke V, Dietel M, Petersen I (1997) Patterns of chromosomal alterations in metastasizing and nonmetastasizing primary head and neck carcinomas. Cancer Res 57:5213–5216
Bockmuhl U, Wolf G, Schmidt S, Schwendel A, Jahnke V, Dietel M, Petersen I (1998) Genomic alterations associated with malignancy in head and neck cancer. Head Neck 20:145–151
Cuny M, Kramar A, Courjal F, Johannsdottir V, Iacopetta B, Fontaine H, Grenier J, Culine S, Theillet C (2000) Relating genotype and phenotype in breast cancer: an analysis of the prognostic significance of amplification at eight different genes or loci and of p53 mutations. Cancer Res 15:1077–1083
Freier K, Joos S, Flechtenmacher C, Devens F, Benner A, Bosch FX, Lichter P, Hofele C (2003) Tissue microarray reveals prevalence of oncogene amplification in head and neck squamous cell carcinoma (HNSCC). Correlation with localization, stage and clinical outcome. Cancer Res 63:179–1182
Gale N, Zidar N, Kambic V, Poljak M, Cor A (1997) Epidermal growth factor receptor, c-HER2 and p53 overexpression in epithelial hyperplastic lesions of the larynx. Acta Otolaryngol Suppl 527:105–110
Gale N, Kambic V, Poljak M, Cor A, Velkavrh D, Mlacak B (2000) Chromosomes 7,17 polysomies and overexpression of epidermal growth factor receptor and p53 protein in epithelial hyperplastic laryngeal lesions. Oncology 58:117–125
Gollin SM (2001) Chromosomal alterations in squamous cell carcinomas of the head and neck: window to the biology of disease. Head Neck 23:238–253
Huang Q, Yu GP, McCormick SA, Mo J, Datta B, Mahimkar M, Lazarus P, Schaffer AA, Desper R, Schantz SP (2002) Genetic differences detected by comparative genomic hybridization in head and neck squamous cell carcinomas from different tumor sites: construction of oncogenetic trees for tumor progression. Genes Chromosomes Cancer 34:224–233
Hermsen M, Guervos MA, Meijer G, Baak J, van Diest P, Marcos CA, Sampedro A (2001) New chromosomal regions with high-level amplifications in squamous cell carcinomas of the larynx and pharynx, identified by comparative genomic hybridization. J Pathol 194:177–182
Kazkayasi M, Hucumenoglu S,Siriner GI, Hucumenoglu M (2001) Over-expression of p53 and c-HER2 oncoproteins in laryngeal carcinoma. Eur Arch Otorhinolaryngol 258:329–335
Khademi B, Shirazi FM, Vasei M, Gandomi B, Modjtahedi H, Pezeshki AM, Ghageri A (2002) The expression of p53, c-EGFR and c-HER2 molecules and their correlation with prognostic markers in patients with head and neck tumors. Cancer Lett 184:223–230
Khan AJ, King BL, Smith BD, Smith GL, DiGoivanna MP, Carter D, Haffty BG (2002) Characterization of HER-2/neu oncogene by immunohistochemical and fluorescence in situ hybridization analysis in oral and oropharyngeal squamous cell carcinoma. Clin Cancer Res 8:540–548
Krecicki T, Jelen M, Zalesska-Krecicka M (1999) C-HER2 immunostaining in laryngeal cancer. Acta Otolaryngol 119:392–395
Leonard JH, Kearsley JH, Chenevix-Trench G, Hayward NK (1991) Analysis of gene amplification in head-and-neck squamous-cell carcinoma. Int J Cancer 48:511–515
Ling L, Zhou MY, Wang HE (2000) Expression of EGFR and PCNA, and DNA content in squamous cell carcinoma of larynx. Lin Chuang Er Bi Yan Hou Ke Za Zhi 14:99–101
Maurizi M, Almadori G, Ferrandina G, Distefano M, Romanini ME, Cadoni G, Benedetti-Panici P, Paludetti G, Scambia G, Mancuso S (1996) Prognostic significance of epidermal growth factor receptor in laryngeal squamous cell carcinoma. Br J Cancer 74:1253–1257
Nocito A, Bubendorf L, Maria Tinner E, Suess K, Wagner U, Forster T, Kononen J, Fijan A, Bruderer J, Schmid U, Ackermann D, Maurer R, Alund G, Knonagel H, Rist M, Anabitarte M, Hering F, Hardmeier T, Schoenenberger AJ, Flury R, Jager P, Luc Fehr J, Schraml P, Moch H, Mihatsch MJ, Gasser T, Sauter G (2001) Microarrays of bladder cancer tissue are highly representative of proliferation index and histological grade. J Pathol 194:349–357
O-Charoenrat P, Rhys-Evans P, Eccles S (2001) Characterization of ten newly-derived human head and neck squamous carcinoma cell lines with special reference to c-erbB proto-oncogene expression. Anticancer Res 21:1953–1963
Ono Y, Nakanishi Y, Gotoh M, Sakamoto M, Hirohashi S (2002) Epidermal growth factor receptor gene amplification is correlated with laminin-5 gamma2 chain expression in oral squamous cell carcinoma cell lines. Cancer Lett 175:197–204
Piccart M, Punt C (2001) Symposium articles. Ann Oncol 12:3–101
Rafferty MA, Fenton JE, Jones AS (2001) An overview of the role and inter-relationship of epidermal growth factor receptor, cyclin D and retinoblastoma protein on the carcinogenesis of squamous cell carcinoma of the larynx. Clin Otolaryngol 26:317–320
Rodrigo JP, Ramos S, Lazo PS, Alvarez I, Suarez C (1996) Amplification of ERBB oncogenes in squamous cell carcinoma of the head and neck. Eur J Cancer 32:2004–2010
Sabin LH, Wittekind C (1997) TNM classification of malignant tumours, 5th edn. Wiley, New York
Schraml P, Kononen J, Bubendorf L, Moch H, Bissig H, Nocito A, Mihatsch MJ, Kallioniemi OP, Sauter G (1999) Tissue microarrays for gene amplification surveys in many different tumor types. Clin Cancer Res 5:1966–1975
Simon R, Richter J, Wagner U, Fijan A, Bruderer J, Schmid U, Ackermann D, Maurer R, Alund G, Knonagel H, Rist M, Wilber K, Anabitarte M, Hering F, Hardmeier T, Schonenberger A, Flury R, Jager P, Fehr JL, Schraml P, Moch H, Mihatsch MJ, Gasser T, Sauter G (2001) High-throughput tissue microarray analysis of 3p25 (RAF1) and 8p12 (FGFR1) copy number alterations in urinary bladder cancer. Cancer Res 61:4514–4519
Speicher MR, Howe C, Crotty P, du Manoir S, Costa J, Ward DC (1995) Comparative genomic hybridization detects novel deletions and amplifications in head and neck squamous cell carcinomas. Cancer Res 55:1010–1013
Takes RP, Baatenburg de Jong RJ, Wijffels K, Schuuring E, Litvinov SV, Hermans J, van Krieken JH (2001) Expression of genetic markers in lymph node metastases compared with their primary tumours in head and neck cancer. J Pathol 194:298–302
Watanabe H, Suzuki T, Ito Y, Mizuta K, Sawai S, Miyata H (1999) Prognostic significance of EGFR and p53 expression, and angiogenesis in laryngeal squamous cell carcinoma. Nippon Jibiinkoka Gakkai Kaiho 102:243–253
Zaharieva BM, Simon R, Diener PA, Ackermann D, Maurer R, Alund G, Knonagel H, Rist M, Wilber K, Hering F, Schonenberger A, Flury R, Jager P, Fehr JL, Mihatsch MJ, Gasser T, Sauter G, Toncheva DI (2003) High-throughput tissue microarray analysis of 11q13 gene_amplification (CCND1, FGF3, FGF4, EMS1) in urinary bladder cancer. J Pathol 201:603–608
Acknowledgments
Supported by the Medical University, Sofia, contract no.12-D
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Koynova, D.K., Tsenova, V.S., Jankova, R.S. et al. Tissue microarray analysis of EGFR and HER2 oncogene copy number alterations in squamous cell carcinoma of the larynx. J Cancer Res Clin Oncol 131, 199–203 (2005). https://doi.org/10.1007/s00432-004-0627-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00432-004-0627-y